Delivery Order SPE2DB22D1106-SPE2DB23FEGH8
Award Date 5/3/23
Potential Completion Date 5/4/23
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $7,326.63 for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded several indefinite delivery contracts (IDCs) by the DLA, including a $999,999,999 IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,619.58 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $1,335.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
- This federal contract award to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product. The $1,919.46 Firm Fixed Price delivery order has an ultimate completion date of October 23, 2023. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products to various government agencies, particularly supporting military and veterans'...
- This federal contract award, valued at $4,567.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vascepa 1 GM Capsule 120S. The contract, valued at $27,009.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $15,047.32 delivery order contract is for the supply of VASCEPA 1 GM capsules, a cardiovascular medication. The contract is a firm fixed-price, Delivery Order type with an ultimate completion date of October 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also...
- This federal contract award, valued at $2,031.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VASCEPA 1 GM CAPSULE 120S. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc. This IDC with the DLA Troop Support Medical serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
- This federal contract award is for the delivery of the pharmaceutical product Vascepa 1 GM Capsule 120S to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $4,584.29 firm fixed-price delivery order was awarded on March 31, 2022 to the prime contractor Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and Department...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Vascepa 1 GM capsules, a cardiovascular medication, with a ceiling value of $1,732.01. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 11, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...